WeedMD Inc. provided revenue guidance for the first quarter ended March 31, 2021. For the quarter, the company expected gross revenues of $12 million represents 72% growth sequential first quarter 2021 versus fourth quarter 2020, reflecting the company’s record sales increase of higher-margin, direct-to-consumer and direct-to-patient products.